Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine plus low-dose terlipressin for septic shock
ChiCTR2200063359Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Sep 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of terlipressin and norepinephrine in septic shock (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Incidence of acute kidney injury and CRRT usage. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
terlipressinnorepinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on ChiCTR2200063359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063359.